Pharmacokinetic Profile of Dalbavancin in Complicated Bacteremia Caused by Staphylococcus aureus: A Secondary Analysis - Top-Institutions - MDSpire

Pharmacokinetic Profile of Dalbavancin in Complicated Bacteremia Caused by Staphylococcus aureus: A Secondary Analysis

  • By

  • Thomas P. Lodise

  • Nicholas A. Turner

  • Toshimitsu Hamasaki

  • Nick Fishbane

  • Varduhi Ghazaryan

  • Alison Wall

  • Lizhao Ge

  • Qihang Wu

  • Lijuan Zeng

  • Todd Riccobene

  • Rinal Patel

  • Smitha Zaharoff

  • Urania Rappo

  • Scott Evans

  • Vance G. Fowler

  • Henry F. Chambers

  • Thomas L. Holland

  • Antibacterial Resistance Leadership Group

  • Robin Patel

  • Heather Cross

  • Anthony Harris

  • Melinda Pettigrew

  • David van Duin

  • Helen Boucher

  • Clayton Huntley

  • Erica Raterman

  • Tamika Samuel

  • Kyung Moon

  • Kim Hanson

  • Yohei Doi

  • Tom Lodise

  • Ritu Banerjee

  • Sara Cosgrove

  • David Paterson

  • Ebbing Lautenbach

  • Maureen Mehigan

  • Sarah Doernberg

  • Sam Perdue

  • April 18, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Infectious Diseases
    • Clinical Pharmacology
    • Microbiology

  • #2

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Pharmacology
    • Clinical Research

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Infectious Diseases
    • Clinical Pharmacology
    • Antimicrobial Research

  • #4

    Washington University School of Medicine
    Washington University School of Medicine

    St. Louis, MO

    Key Differentiators

    • Infectious Diseases
    • Pharmacology
    • Clinical Trials

  • #5

    University of Pittsburgh Medical Center (UPMC)
    University of Pittsburgh Medical Center (UPMC)

    Pittsburgh, PA

    Key Differentiators

    • Infectious Diseases
    • Clinical Pharmacology
    • Antimicrobial Stewardship

Original Source(s)

Pharmacokinetic Profile of Dalbavancin in Complicated Bacteremia Caused by Staphylococcus aureus: A Secondary Analysis

  • by Thomas P. Lodise, Nicholas A. Turner, Toshimitsu Hamasaki, Nick Fishbane, Varduhi Ghazaryan, Alison Wall, Lizhao Ge, Qihang Wu, Lijuan Zeng, Todd Riccobene, Rinal Patel, Smitha Zaharoff, Urania Rappo, Scott Evans, Vance G. Fowler, Henry F. Chambers, Thomas L. Holland, Antibacterial Resistance Leadership Group, Robin Patel, Heather Cross, Anthony Harris, Melinda Pettigrew, David van Duin, Helen Boucher, Clayton Huntley, Erica Raterman, Tamika Samuel, Kyung Moon, Kim Hanson, Yohei Doi, Tom Lodise, Ritu Banerjee, Sara Cosgrove, David Paterson, Ebbing Lautenbach, Maureen Mehigan, Sarah Doernberg, Sam Perdue

  • April 18, 2026

Related Content

Clinical Features, Microbial Profiles, and Antimicrobial Resistance in Neonates with Bloodstream Infections Due to ESKAPEEc Pathogens in Southwest China

When Obesity Meets Infection Risk

Researchers analyze data from Finnish cohorts and the UK Biobank to examine how body mass index relates to severe infections and their global burden.

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.